Augmedix Inc. (AUGX)
NASDAQ: AUGX
· Real-Time Price · USD
2.35
0.00 (0.00%)
At close: Oct 01, 2024, 9:57 PM
Augmedix Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 51.58M | 48.7M | 44.85M | 40.93M | 37.02M | 33.58M | 30.93M | 28.76M | 26.52M | 24.36M | 22.16M | 20.13M | 18.75M | 17.3M |
Cost of Revenue | 26.71M | 25.22M | 23.33M | 21.6M | 19.93M | 18.35M | 16.98M | 15.92M | 14.73M | 13.37M | 12.16M | 11.05M | 10.33M | 9.76M |
Gross Profit | 24.87M | 23.48M | 21.53M | 19.33M | 17.09M | 15.23M | 13.95M | 12.84M | 11.79M | 10.99M | 10.01M | 9.08M | 8.42M | 7.54M |
Operating Income | -23.88M | -20.09M | -19.33M | -20.42M | -21.48M | -22.6M | -22.39M | -21.78M | -21M | -18.98M | -17.94M | -16.68M | -15.36M | -13.88M |
Interest Income | 1.58M | 1.45M | 1.11M | 903K | 674K | 402K | 245K | 75K | 17K | 16K | 14.97K | 15.8K | 14.8K | 14.8K |
Pretax Income | -23.86M | -20.53M | -19.19M | -20.28M | -21.36M | -23.77M | -24.47M | -24.32M | -21.69M | -18.88M | -17.85M | -16.19M | -17.45M | -15.77M |
Net Income | -23.85M | -20.43M | -19.2M | -20.47M | -21.59M | -25.39M | -26.06M | -25.75M | -23.09M | -18.88M | -17.85M | -16.19M | -17.45M | -15.77M |
Selling & General & Admin | 34.62M | 31.27M | 29.13M | 28.35M | 27.5M | 26.69M | 26.2M | 25.14M | 24.1M | 22.44M | 21.27M | 19.99M | 18.81M | 16.96M |
Research & Development | 14.13M | 12.3M | 11.18M | 10.85M | 10.52M | 10.58M | 10.15M | 9.48M | 8.68M | 7.53M | 6.68M | 5.77M | 4.97M | 4.46M |
Other Expenses | 26K | -73K | -9K | -103K | -131K | -32K | -32K | -32K | n/a | n/a | n/a | n/a | n/a | 27K |
Operating Expenses | 48.75M | 43.57M | 40.3M | 39.2M | 38.02M | 37.27M | 36.35M | 34.62M | 32.78M | 29.97M | 27.95M | 25.76M | 23.78M | 21.42M |
Interest Expense | 2.54M | 2.46M | 2.25M | 1.98M | 1.66M | 1.48M | 1.68M | 1.92M | 2.19M | 2.41M | 2.5M | 2.14M | 1.95M | 1.79M |
Selling & Marketing Expenses | 12.79M | 11.69M | 10.69M | 10.28M | 9.86M | 9.64M | 9.31M | 9.02M | 8.87M | 8.16M | 7.51M | 6.91M | 5.64M | 4.73M |
Cost & Expenses | 75.46M | 68.78M | 63.63M | 60.8M | 57.95M | 55.62M | 53.33M | 50.54M | 47.52M | 43.34M | 40.1M | 36.81M | 34.12M | 31.18M |
Income Tax Expense | 66K | 31K | 144K | 327K | 275K | 1.62M | 1.25M | 1.09M | 1.87M | 474K | 813K | 812K | -212K | -215K |
Shares Outstanding (Basic) | 53.39M | 53.06M | 49.02M | 45.52M | 43.61M | 37.49M | 37.44M | 37.43M | 37.42M | 37.4M | 34.42M | 27.12M | 27.02M | 26.86M |
Shares Outstanding (Diluted) | 53.39M | 53.06M | 49.02M | 45.52M | 43.61M | 37.49M | 37.44M | 37.43M | 37.42M | 37.4M | 34.65M | 27.12M | 27.02M | 26.86M |
EPS (Basic) | -0.47 | -0.43 | -0.45 | -0.51 | -0.56 | -0.68 | -0.7 | -0.71 | -0.67 | -0.6 | -0.62 | -0.61 | -0.65 | -0.59 |
EPS (Diluted) | -0.47 | -0.43 | -0.45 | -0.51 | -0.56 | -0.68 | -0.7 | -0.71 | -0.67 | -0.6 | -0.62 | -0.6 | -0.64 | -0.58 |
EBITDA | -20.74M | -17.6M | -16.34M | -17.39M | -18.96M | -20.85M | -21.37M | -20.94M | -17.93M | -15.75M | -14.72M | -13.41M | -14.56M | -13M |
EBIT | -21.24M | -17.94M | -16.77M | -18.02M | -19.49M | -22.02M | -22.62M | -22.35M | -19.34M | -16.42M | -15.23M | -13.93M | -15.49M | -13.98M |
Depreciation & Amortization | 1.62M | 1.61M | 1.56M | 1.61M | 1.6M | 1.58M | 1.53M | 1.35M | 1.04M | 863K | 725.59K | 778.59K | 836.59K | 850.94K |